• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL12/CXCR7/β-抑制蛋白1偏向性信号通过YAP1核转位抑制微小RNA,从而促进结直肠癌的上皮-间质转化。

CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.

作者信息

Si Mahan, Song Yujia, Wang Xiaohui, Wang Dong, Liu Xiaohui, Qu Xianjun, Song Zhiyu, Yu Xinfeng

机构信息

Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

出版信息

Cell Biosci. 2022 Oct 9;12(1):171. doi: 10.1186/s13578-022-00908-1.

DOI:10.1186/s13578-022-00908-1
PMID:36210463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9549625/
Abstract

BACKGROUND

Chemokine CXC motif receptor 7 (CXCR7) is an atypical G protein-coupled receptor (GPCR) that signals in a biased fashion. CXCL12/CXCR7 biased signal has been reported to play crucial roles in multiple stages of colorectal cancer (CRC). However, the mechanism of CXCL12/CXCR7 biased signal in promoting CRC progression and metastasis remains obscure.

RESULTS

We demonstrate that CXCR7 activation promotes EMT and upregulates the expression of Vimentin and doublecortin-like kinase 1 (DCLK1) in CRC cells with concurrent repression of miR-124-3p and miR-188-5p through YAP1 nuclear translocation. Cell transfection and luciferase assay prove that these miRNAs regulate EMT by targeting Vimentin and DCLK1. More importantly, CXCL12/CXCR7/β-arrestin1-mediated biased signal induces YAP1 nuclear translocation, which functions as a transcriptional repressor by interacting with Yin Yang 1 (YY1) and recruiting YY1 to the promoters of miR-124-3p and miR-188-5p. Pharmacological inhibitor of YAP1 suppresses EMT and tumor metastasis upon CXCR7 activation in vivo in tumor xenografts of nude mice and inflammatory colonic adenocarcinoma models. Clinically, the expression of CXCR7 is positively correlated with nuclear YAP1 levels and EMT markers.

CONCLUSIONS

Our studies reveal a novel mechanism and clinical significance of CXCL12/CXCR7 biased signal in promoting EMT and invasion in CRC progression. These findings highlight the potential of targeting YAP1 nuclear translocation in hampering CXCL12/CXCR7 biased signal-induced metastasis of colorectal cancer.

摘要

背景

趋化因子CXC基序受体7(CXCR7)是一种非典型G蛋白偶联受体(GPCR),以偏向性方式发出信号。据报道,CXCL12/CXCR7偏向性信号在结直肠癌(CRC)的多个阶段发挥关键作用。然而,CXCL12/CXCR7偏向性信号促进CRC进展和转移的机制仍不清楚。

结果

我们证明,CXCR7激活通过YAP1核转位促进CRC细胞中的上皮-间质转化(EMT),并上调波形蛋白和双皮质素样激酶1(DCLK1)的表达,同时抑制miR-124-3p和miR-188-5p。细胞转染和荧光素酶测定证明,这些微小RNA通过靶向波形蛋白和DCLK1调节EMT。更重要的是,CXCL12/CXCR7/β-抑制蛋白1介导的偏向性信号诱导YAP1核转位,YAP1通过与阴阳1(YY1)相互作用并将YY1募集到miR-124-3p和miR-188-5p的启动子上,作为转录抑制因子发挥作用。YAP1的药理学抑制剂在裸鼠肿瘤异种移植和炎症性结肠腺癌模型中,可在体内抑制CXCR7激活后的EMT和肿瘤转移。在临床上,CXCR7的表达与核YAP1水平和EMT标志物呈正相关。

结论

我们的研究揭示了CXCL12/CXCR7偏向性信号在促进CRC进展中的EMT和侵袭方面的新机制及临床意义。这些发现突出了靶向YAP1核转位在阻碍CXCL12/CXCR7偏向性信号诱导的结直肠癌转移中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/a56359266a3e/13578_2022_908_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/1c415701b7df/13578_2022_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/4e4e67d18710/13578_2022_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/5077078edb2b/13578_2022_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/04124d171515/13578_2022_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/f39a18718de8/13578_2022_908_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/26a52a83a172/13578_2022_908_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/a90eb6440f6c/13578_2022_908_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/a56359266a3e/13578_2022_908_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/1c415701b7df/13578_2022_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/4e4e67d18710/13578_2022_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/5077078edb2b/13578_2022_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/04124d171515/13578_2022_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/f39a18718de8/13578_2022_908_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/26a52a83a172/13578_2022_908_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/a90eb6440f6c/13578_2022_908_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/9549625/a56359266a3e/13578_2022_908_Fig8_HTML.jpg

相似文献

1
CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.CXCL12/CXCR7/β-抑制蛋白1偏向性信号通过YAP1核转位抑制微小RNA,从而促进结直肠癌的上皮-间质转化。
Cell Biosci. 2022 Oct 9;12(1):171. doi: 10.1186/s13578-022-00908-1.
2
Exosomal miR-146a-5p and miR-155-5p promote CXCL12/CXCR7-induced metastasis of colorectal cancer by crosstalk with cancer-associated fibroblasts.外泌体 miR-146a-5p 和 miR-155-5p 通过与肿瘤相关成纤维细胞的串扰促进 CXCL12/CXCR7 诱导的结直肠癌转移。
Cell Death Dis. 2022 Apr 20;13(4):380. doi: 10.1038/s41419-022-04825-6.
3
CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.CXCR7 并非人卵巢癌细胞上皮间质转化所必需的 CXCL12-CXCR4 诱导因素。
Mol Carcinog. 2019 Jan;58(1):144-155. doi: 10.1002/mc.22916. Epub 2018 Oct 16.
4
CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.CXCL12/CXCR4 通过海绵吸附 miR-133a-3p 激活 RhoA 信号促进炎症驱动的结直肠癌进展。
J Exp Clin Cancer Res. 2019 Jan 24;38(1):32. doi: 10.1186/s13046-018-1014-x.
5
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.综合分析确定微小RNA-195是结直肠癌中Hippo-YAP信号通路的抑制因子。
J Hematol Oncol. 2017 Mar 29;10(1):79. doi: 10.1186/s13045-017-0445-8.
6
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用:临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
7
Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.外泌体包裹的 miRNA 通过增强巨噬细胞的 M2 极化促进结直肠癌 CXCL12/CXCR4 诱导的肝转移。
Cancer Lett. 2020 Apr 1;474:36-52. doi: 10.1016/j.canlet.2020.01.005. Epub 2020 Jan 10.
8
MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.微小 RNA-200b-3p 通过 C-X-C 基序趋化因子配体 12/CXC 趋化因子受体 7 轴抑制胃癌细胞增殖、迁移和侵袭。
Bioengineered. 2022 Mar;13(3):6509-6520. doi: 10.1080/21655979.2022.2034585.
9
MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.miR-142-5p 通过靶向 Yin Yang 1 抑制上皮-间质转化调控肺癌细胞转移。
Cell Reprogram. 2020 Dec;22(6):328-336. doi: 10.1089/cell.2020.0023.
10
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.微小RNA-103a-3p通过河马/Yes相关蛋白1/缺氧诱导因子1α轴促进结直肠癌的肿瘤糖酵解。
J Exp Clin Cancer Res. 2020 Nov 20;39(1):250. doi: 10.1186/s13046-020-01705-9.

引用本文的文献

1
The Use of Biologics for Targeting GPCRs in Metastatic Cancers.生物制剂在转移性癌症中靶向G蛋白偶联受体的应用
BioTech (Basel). 2025 Jan 30;14(1):7. doi: 10.3390/biotech14010007.
2
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases.CXCL12/CXCR4/CXCR7轴在与神经退行性疾病相关的认知障碍中的作用。
Brain Behav Immun Health. 2024 Dec 24;43:100932. doi: 10.1016/j.bbih.2024.100932. eCollection 2025 Feb.
3
PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer.

本文引用的文献

1
Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis.ZEB1功能的调控以及其在肿瘤进展和转移中的分子关联
Cancers (Basel). 2022 Apr 7;14(8):1864. doi: 10.3390/cancers14081864.
2
Upregulating CXCR7 accelerates endothelial progenitor cell-mediated endothelial repair by activating Akt/Keap-1/Nrf2 signaling in diabetes mellitus.上调 CXCR7 通过激活 Akt/Keap-1/Nrf2 信号通路加速糖尿病患者内皮祖细胞介导的内皮修复。
Stem Cell Res Ther. 2021 May 3;12(1):264. doi: 10.1186/s13287-021-02324-7.
3
Allosteric coupling and biased agonism in G protein-coupled receptors.
PRDX1 通过作为结直肠癌细胞中的分子伴侣与 Cullin-3 结合来抑制铁死亡。
Int J Biol Sci. 2024 Sep 23;20(13):5070-5086. doi: 10.7150/ijbs.99804. eCollection 2024.
4
Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicator.重新定义小细胞肺癌中的YAP1:从主要亚型标志物转变为有利的预后指标。
Transl Lung Cancer Res. 2024 Aug 31;13(8):1768-1779. doi: 10.21037/tlcr-24-317. Epub 2024 Aug 17.
5
Function of microRNA‑124 in the pathogenesis of cancer (Review).微小 RNA-124 在癌症发病机制中的功能(综述)。
Int J Oncol. 2024 Jan;64(1). doi: 10.3892/ijo.2023.5594. Epub 2023 Dec 1.
6
Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.CXCR7 对胃癌发生过程中 Hippo/YAP 轴的调控
J Exp Clin Cancer Res. 2023 Nov 10;42(1):297. doi: 10.1186/s13046-023-02870-3.
7
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.CXCL12轴在胰腺癌中的作用:新的生物标志物和潜在靶点。
Front Oncol. 2023 Mar 23;13:1154581. doi: 10.3389/fonc.2023.1154581. eCollection 2023.
8
An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.一个与结肠腺癌预后、免疫浸润和治疗反应相关的上皮-间充质转化相关 mRNA 特征。
Pathol Oncol Res. 2023 Feb 24;29:1611016. doi: 10.3389/pore.2023.1611016. eCollection 2023.
变构偶联和 G 蛋白偶联受体的偏激动效应。
FEBS J. 2021 Apr;288(8):2513-2528. doi: 10.1111/febs.15783. Epub 2021 Mar 5.
4
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.锌依赖的 ZEB1 和 YAP1 共激活调控促进胰腺癌上皮-间质转化可塑性和转移。
Gastroenterology. 2021 Apr;160(5):1771-1783.e1. doi: 10.1053/j.gastro.2020.12.077. Epub 2021 Jan 6.
5
CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2.CXCR7:一种偏向β-抑制蛋白的受体,可增强细胞迁移,并仅通过Gβγ亚基和GRK2募集β-抑制蛋白2。
Cell Biosci. 2020 Nov 23;10(1):134. doi: 10.1186/s13578-020-00497-x.
6
EMT imparts cancer stemness and plasticity: new perspectives and therapeutic potential.上皮-间质转化赋予癌症干性和可塑性:新观点与治疗潜力
Front Biosci (Landmark Ed). 2021 Jan 1;26(2):238-265. doi: 10.2741/4893.
7
Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.CXCR7 在结直肠腺瘤和腺癌中的表达:与临床病理参数的相关性。
Ann Diagn Pathol. 2020 Dec;49:151621. doi: 10.1016/j.anndiagpath.2020.151621. Epub 2020 Sep 6.
8
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.EMT 转录因子 ZEB1 在乳腺癌中与 YAP 和 AP-1 的全基因组合作。
EMBO J. 2020 Sep 1;39(17):e103209. doi: 10.15252/embj.2019103209. Epub 2020 Jul 21.
9
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.超越细胞迁移:趋化因子及其受体在恶性肿瘤中的作用不断扩大。
Front Immunol. 2020 Jun 4;11:952. doi: 10.3389/fimmu.2020.00952. eCollection 2020.
10
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.YAP 介导的 YY1 和 EZH2 的募集抑制关键细胞周期调节剂的转录。
Cancer Res. 2020 Jun 15;80(12):2512-2522. doi: 10.1158/0008-5472.CAN-19-2415. Epub 2020 May 14.